Evoq Remedies (BOM:543500) Debt-to-Asset : 0.12 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Evoq Remedies Debt-to-Asset?

Evoq Remedies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹42.38 Mil. Evoq Remedies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.00 Mil. Evoq Remedies's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was ₹368.61 Mil. Evoq Remedies's debt to asset for the quarter that ended in Mar. 2024 was 0.11.

Evoq Remedies Debt-to-Asset Historical Data

The historical data trend for Evoq Remedies's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoq Remedies Debt-to-Asset Chart

Evoq Remedies Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.25

0.27

0.12

Evoq Remedies Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial				0.25	0.26	0.27	0.04	0.12

Competitive Comparison of Evoq Remedies's Debt-to-Asset

For the Medical Distribution subindustry, Evoq Remedies's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evoq Remedies's Debt-to-Asset Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Evoq Remedies's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Evoq Remedies's Debt-to-Asset falls into.

Evoq Remedies Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Evoq Remedies's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(42.382	+	0)	/	368.61
	=	0.11

Evoq Remedies's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(42.382	+	0)	/	368.61
	=	0.11

Evoq Remedies (BOM:543500) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Evoq Remedies Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Evoq Remedies's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoq Remedies (BOM:543500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Evoq Remedies Ltd (BOM:543500) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Science City Road, A-1106, Empire Business Hub, Near AUDA Water Tank, Sola, Ahmedabad, GJ, IND, 380060

Website

http://www.evoqremedies.com

Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.

Evoq Remedies (BOM:543500) Headlines

No Headlines